( CNSX:FLU,NASDAQ-OTCBB:ATTBF )

News from abattis bioceuticals corp A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Mar 12, 2013, 15:38 ET Abattis Provides $10,000 Sponsorship to the American Herbal Pharmacopoeia for Cannabis Monograph Project

 Abattis Bioceuticals Corp (OTC PINK: ATTBF) (CNSX: FLU) today announced that it has provided $10,000 sponsorship for the cannabis (cannabis...


Mar 11, 2013, 14:31 ET Abattis Terminates $600,000 Private Placement

VANCOUVER, March 11, 2013 /CNW/ - Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), announces that it will not be...


Mar 08, 2013, 15:53 ET Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance

Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), is pleased to announce its participation in a research project...


Mar 06, 2013, 07:23 ET Abattis Signs LOI With Crudessence Kombucha Inc. To License Infused, Blended Kombucha Tea

 Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has signed a letter of intent with...


Mar 05, 2013, 05:00 ET Abattis Signs LOI to be North American Distributor of Cromogen's Cannabinoid Class Compound "Cannabidiol" or "CBD"

VANCOUVER, March 5, 2013 /PRNewswire/ - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has...


Mar 04, 2013, 07:47 ET Dr. Paula Brown appointed to board of wholly owned subsidiary Biocell Labs Inc. and acquires formulations

VANCOUVER, March 4, 2013 /PRNewswire/ - Biocell Labs Inc., a wholly owned subsidiary of Abattis Bioceuticals Corp. (the "Company" or "Abattis")...


Feb 04, 2013, 05:00 ET Abattis engages British Columbia Institute of Technology to study growth rates and compounds in spinach

VANCOUVER, Feb. 4, 2013 /PRNewswire/ - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces the...


Jan 16, 2013, 05:00 ET Abattis receives US and Taiwan trademark approvals for anti-viral brand Defenzall™

VANCOUVER, Jan. 16, 2013 /PRNewswire/ - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces it has...


Jan 14, 2013, 14:43 ET Abattis signs Andrew Riseman, Ph.D. Associate Professor, Applied Biology and Plant Breeding

VANCOUVER, Jan. 14, 2013 /PRNewswire/ - Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTC PINK: ATTBF) (CNSX: FLU), announces the...